Shanghai Henlius Biotech (2E8.F) Q3 2026 Earnings

25AugConfirmed
Q3 2025
Q1 2026
0.07
0.08
0.09
0.1

Details

Expected EPS
0.053797526094
Actual EPS
N/A
Surprise EPS
-0.05
Surprise Percent
+100%

Description

Shanghai Henlius Biotech (2E8.F) will report earnings of for Q3 2026 on August 25, 2026.

0 Comments

Share your thoughts